00:00:00 | How the Zetasizer Nano can be used to benefit your drug delivery applications |
00:01:13 | How the Zetasizer Nano can be used to benefit your drug delivery applications |
00:02:00 | Overview |
00:03:02 | DLS = Dynamic light scattering |
00:03:51 | Some Malvern DLS References |
00:04:48 | ELS = Electrophoretic light scattering |
00:06:08 | Some Malvern ELS References |
00:07:08 | Dextran/DNA Nanoplex for gene delivery |
00:08:35 | Colloidal phytosterol particles for delivery |
00:09:16 | Stabilization of Liposomes |
00:10:23 | Iron Oxide Nanoparticles for MRI |
00:11:33 | PLGA nanoparticles for drug delivery |
00:12:22 | Microparticles for anaesthetic agent delivery |
00:13:07 | Mannosylated Liposomes for Vaccines |
00:13:47 | Adjuvants, immune response |
00:15:15 | Paclitaxel delivery via nanoparticles |
00:16:04 | Polyglutamic Acid (PGA) for drug delivery |
00:16:58 | Gold nano particles for delivery |
00:17:35 | Chitosan/siRNA complexes |
00:18:50 | Lysine dendrimer |
00:19:49 | Nanoparticles and PEGylation |
00:20:27 | For example PEGylated dendrimers… |
00:21:14 | MRK675 Optimizing Topical Formulations |
00:22:18 | MRK1228 Size change of lipid nanoparticles |
00:22:54 | MRK670 Microemulsion characterisation |
00:23:29 | MRK575 Size and zeta of Liposomes |
00:24:15 | MRK307 Zeta potential in gene therapy |
00:25:33 | MRK1379 Protein Chitosan Complex |
00:26:22 | Relevance for Real Applications |
00:27:28 | Summary |
00:28:41 | Thank You! |
00:29:40 | Contact Information |
This presentation examines select publications in the field of nanoparticles used for controlled release drug delivery. Applications include PGA, siRNA, lysine, dendrimer nanoparticles and the effect of storage and PEGylation